Skip to main content

Fox Most Popular

FDA warns on hepatitis C drugs

10 years 1 month ago
The Food and Drug Administration is warning about the risk of reactivation of hepatitis B among patients who have had that disease and who are taking some prominent and expensive newer medicines for hepatitis C. The federal agency said it is requiring a so-called black-box warning in the labels for at least nine brand-name direct-acting antiviral drugs, including Sovaldi and Harvoni from Gilead Sciences Inc., Viekira Pak from AbbVie Inc.
Checked
2 weeks 2 days ago
Fox Most Popular
Discover the latest breaking news feed with Fox. Find out what the latest news is and read about the latest news happening today.
Subscribe to Fox Most Popular feed